Referral

Gynaecomastia

  • Gynaecomastia in young men may be pubertal (physiological), or drug related these patients do not need referral and need reassurance
  • Gynaecomastia in older men – review medication as this is commonly a side effect of their treatment for another condition
Toggle all

Investigations in patients presenting with symptoms and/or signs suggestive of breast cancer, investigation prior to referral is not recommended

For those with soft swelling which is unlikely to be due to malignancy consider:

  • Bloods
    (fbc/lft/u&e/oestradial/fsh/lh/testosterone/sex hormone binding globulin/alpha feto protein/beta hcg and prolactin)

  • Gynaecomastia in young men may be:
    • pubertal (physiological)
    • drug related e.g. spironolactone, digoxin, phenothiazines, epilim, PPIs, cimetidine, finasteride, anabolic steroids, cannabis
    • these patients do not need referral and need reassurance
  • Gynaecomastia in older men – review medication as this is commonly a side effect of their treatment for another condition. E.g. spironolactone, digoxin, phenothiazines, epilim, PPIs, cimetidine, finasteride, Suggest stop the drug and review

Referral Criteria

A 2WW Referral should be made

  • For male patients, aged 50 years and older with a unilateral, firm subareolar mass with or without nipple distortion or associated skin changes

Referral Instructions

Use the e-Referral Service to book the appointment, if no appointment available, click "defer to provider"

  • Priority: 2WW
  • Service: 2WW
  • Clinic type: 2WW Breast
  • Service: 2WW Breast Male - NDHCT - NDDH - RBZ

Referral Form

Patient Information

Breast Cancer Care

Pathway Group

This guideline has been signed off on behalf of NHS Devon.

Publication date: June 2017